Daria and Sophie join the Dynamic42 lab team as permanent members
We are delighted to announce that after their Master studies Daria and Sophie will join our team permanently as research assistants.
Both Daria and Sophie studied at the Department of Pharmaceutical Biotechnology at the Ernst-Abbe University of Applied Sciences (EAH). Sophie focussed on the emulation of an inflammatory bowel disease (IBD) model in her Master thesis working in close cooperation with her supervisors Dr. Katja Graf and Tim Kaden. In this research project, a microphysiological intestinal model was leveraged as a platform to investigate the protective effects of probiotic lactic acid bacterium Lactobacillus rhamnosus GG on host tissue during inflammatory responses in IBD.
Daria’s Master thesis was about the immune-related side effects and the toxicity of therapeutic antibodies focus on liver cells. This study was conducted in close cooperation with her supervisors Anne-Kathrin Bothe and Dr. Martin Raasch from Dynamic42.
Both are particularly interest in developing innovative technology that recapitulates the human anatomy and physiology, allowing for more realistic disease modelling, underlying molecular mechanisms and potential therapy targets. Further, they have an invested interest to contribute to the reduction of animal experiment through the organ-on-a-chip platforms they develop.
Daria and Sophie first gained insights into the work at Dynamic42, through their degree program, as part of the module ‘In-vitro diagnostics’.
If you have questions about us or our programme for students and doctoral candidates, please get in touch!